Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aziyo Biologics Inc Cl A
(NQ:
AZYO
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Sep 6, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aziyo Biologics Inc Cl A
< Previous
1
2
3
Next >
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
December 01, 2022
Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 01, 2022
Via
Benzinga
A Look Into Aziyo Biologics' Debt
December 01, 2022
Over the past three months, shares of Aziyo Biologics Inc. (NASDAQ:AZYO) fell by 45.96%. Before having a look at the importance of debt, let's look at how much debt Aziyo Biologics has.
Via
Benzinga
Aziyo Biologics: Q2 Earnings Insights
August 11, 2022
Aziyo Biologics (NASDAQ:AZYO) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Nasdaq Turns Lower; Dow Tumbles Over 300 Points
December 01, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 300 points on Thursday.
Via
Benzinga
What Does Aziyo Biologics' Debt Look Like?
December 01, 2022
Over the past three months, shares of Aziyo Biologics Inc. (NASDAQ:AZYO) decreased by 45.14%. When understanding a companies price change over a time period like 3 months, it could be helpful to look...
Via
Benzinga
Looking Into Aziyo Biologics's Recent Short Interest
December 01, 2022
Aziyo Biologics's (NASDAQ:AZYO) short percent of float has fallen 6.45% since its last report. The company recently reported that it has 5 thousand shares sold short, which is 0.29% of all regular...
Via
Benzinga
US Stocks Mixed After Wednesday's Rally
December 01, 2022
U.S. stocks traded mixed this morning, with the Dow Jones falling around 180 points on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 01, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 01, 2022
Good morning! We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about!
Via
InvestorPlace
Why Okta Shares Are Trading Higher By Around 14%; Here Are 27 Stocks Moving Premarket
December 01, 2022
Gainers Pacifico Acquisition Corp. (NASDAQ: PAFO) shares rose 40.9% to $7.58 in pre-market trading after dipping around 43% on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 30, 2022
Via
Benzinga
Preview: Aziyo Biologics's Earnings
November 11, 2022
Aziyo Biologics (NASDAQ:AZYO) is set to give its latest quarterly earnings report on Monday, 2022-11-14. Here's what investors need to know before the announcement. Analysts estimate that Aziyo...
Via
Benzinga
A Preview Of Aziyo Biologics's Earnings
May 06, 2022
Aziyo Biologics (NASDAQ:AZYO) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Aziyo...
Via
Benzinga
68 Biggest Movers From Yesterday
April 19, 2022
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 18, 2022
Gainers Natus Medical (NASDAQ:NTUS) shares rose 28.8% to $33.55 during Monday's regular session. The current volume of 3.0 million shares is 2073.2% of Natus Medical...
Via
Benzinga
Analysts Cut Price Target On Aziyo Biologics As Q4 Earnings Fall Short Of Expectations
March 04, 2022
Aziyo Biologics Inc (NASDAQ: AZYO) Q4 FY21 sales decreased 13% to $10.9 million, missing the consensus of $11.06 million. Excluding the contribution of...
Via
Benzinga
Aziyo Biologics: Q4 Earnings Insights
March 03, 2022
Aziyo Biologics (NASDAQ:AZYO) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
45 Biggest Movers From Yesterday
December 29, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares climbed 64.8% to close at $19.02 on Tuesday as traders circulated a social media post on a potential short squeeze. ShiftPixy...
Via
Benzinga
Earnings Scheduled For March 3, 2022
March 03, 2022
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...
Via
Benzinga
78 Biggest Movers From Friday
February 14, 2022
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 08, 2021
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's...
Via
Benzinga
58 Biggest Movers From Yesterday
December 14, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...
Via
Benzinga
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M...
Via
Benzinga
52 Biggest Movers From Yesterday
December 09, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares surged 84.1% to close at $19.11 on Wednesday. Insignia Systems recently announced the commencement of a formal process to...
Via
Benzinga
44 Biggest Movers From Yesterday
October 15, 2021
Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after...
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...
Via
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.